The U.S. Food and Drug Administration is working with Deerfield, Ill.-based Baxter Healthcare, Evanston, Ill.-based B. Braun Medical and Lake Forest, Ill.-based Hospira to address the issue, according to the news release.
More Articles on the FDA:
FDA Bans Ranbaxy Laboratories From Manufacturing, Importing Drugs
FDA Drug Approval Processes Not Consistent
FDA Appoints Dr. Rafael Miguel to Anesthetic and Analgesic Drug Products Advisory Committee
Next Up in Supply Chain
-
Becker’s asked supply chain leaders: What’s the most productive partnership supply chain has with another department at your system, and…
-
Medline is laying off 304 workers, according to a notice filed with the state of Illinois and a Nov. 5…
-
As hospitals redefine the role of supply chain leaders to focus on enterprise strategy, digital transformation and resilience, health systems…
Join the 500,000+ healthcare executives who start their day with Becker's
Becker's Hospital Review Newsletter is sent Monday–Sunday.
